BOSTON FAMILY OFFICE LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
BOSTON FAMILY OFFICE LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2020$673,000
-6.5%
8,3680.0%0.06%
-12.9%
Q2 2020$720,000
+6.0%
8,3680.0%0.07%
-12.5%
Q1 2020$679,000
+0.9%
8,368
+4.0%
0.08%
+25.0%
Q4 2019$673,000
-5.1%
8,050
-0.6%
0.06%
-13.5%
Q3 2019$709,000
+6.9%
8,1000.0%0.07%
+7.2%
Q2 2019$663,000
+0.6%
8,1000.0%0.07%
-2.8%
Q1 2019$659,000
+23.6%
8,1000.0%0.07%
+7.6%
Q4 2018$533,000
-14.6%
8,1000.0%0.07%0.0%
Q3 2018$624,000
+4.3%
8,1000.0%0.07%
-2.9%
Q2 2018$598,000
+13.5%
8,1000.0%0.07%
+13.3%
Q1 2018$527,000
+0.6%
8,1000.0%0.06%
+3.4%
Q4 2017$524,000
+3.1%
8,1000.0%0.06%0.0%
Q3 2017$508,000
+3.7%
8,1000.0%0.06%0.0%
Q2 2017$490,000
+14.2%
8,100
-2.1%
0.06%
+9.4%
Q1 2017$429,000
+16.9%
8,2750.0%0.05%
+10.4%
Q4 2016$367,000
-4.9%
8,275
+2.2%
0.05%
-4.0%
Q3 2016$386,000
+5.5%
8,1000.0%0.05%
+6.4%
Q2 2016$366,000
+72.6%
8,100
+56.8%
0.05%
+67.9%
Q1 2016$212,000
+5.5%
5,165
-2.0%
0.03%0.0%
Q4 2015$201,000
-44.3%
5,272
+2.1%
0.03%
-37.8%
Q2 2015$361,000
+2.0%
5,1650.0%0.04%
+2.3%
Q1 2015$354,000
-16.3%
5,165
-10.4%
0.04%
-17.0%
Q4 2014$423,000
+2.2%
5,7650.0%0.05%0.0%
Q3 2014$414,000
-0.7%
5,7650.0%0.05%0.0%
Q2 2014$417,000
-5.7%
5,765
-3.9%
0.05%
+82.8%
Q1 2014$442,000
+111.5%
6,000
+100.0%
0.03%
+3.6%
Q4 2013$209,000
+0.5%
3,0000.0%0.03%
-12.5%
Q2 2013$208,0003,0000.03%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders